Anthia Govender | Medical Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Ms. Anthia Govender | Medical Biochemistry | Best Researcher Award

PhD student at University of Kwa-Zulu Natal, South Africa

Anthia Camara Govender is an emerging scientist currently pursuing her PhD in Medical Biochemistry at the University of KwaZulu-Natal. With a strong academic background and early research contributions in toxicology and epigenetics, she has quickly established herself as a promising researcher in the biomedical field. Anthia’s work primarily investigates the cellular and molecular effects of environmental toxins such as mycotoxins, with a specific focus on their impact on lung tissue and genetic regulation. Her dedication to uncovering new insights in medical biochemistry reflects a clear commitment to advancing translational science and therapeutic strategies.

profile

orcid

Education

Anthia’s academic journey began with her matriculation from Sathya Sai School, Chatsworth, in 2019. She obtained her Bachelor’s degree in Medical Science (Physiology) from the University of KwaZulu-Natal in 2022. Her strong academic performance continued as she graduated cum laude in both her Honours in Medical Science (Medical Biochemistry) in 2023 and her Master’s degree in Medical Science (Medical Biochemistry) in 2024. Currently, she is enrolled in a PhD program at the same university, focusing her doctoral research on the toxicological effects of fumonisins on pulmonary epigenetics and cellular dysfunction.

Experience

Although at the early stage of her professional career, Anthia has already undertaken significant research responsibilities through her postgraduate projects. Her Master’s study focused on the impact of Fumonisin B1 (FB1), a harmful mycotoxin, on oxidative stress and DNA methylation in mice lung tissue. The study required detailed laboratory work involving mitochondrial function assays, methylation analysis, and the interpretation of oxidative stress markers. Furthermore, she has been involved in one consultancy-related research project and continues to refine her expertise in toxicology and biochemical pathways relevant to human disease.

Research Interest

Anthia’s research interests are deeply rooted in medical biochemistry, with a focus on toxicology, mycotoxins, epigenetics, and oxidative stress. Her academic progression into PhD-level work demonstrates a growing interest in exploring how environmental toxins disrupt biological systems at a molecular level. She is particularly fascinated by the mechanisms of mitophagy, DNA hypermethylation, and how these contribute to disease pathogenesis. Through her studies, she aims to bridge gaps in current understanding and contribute to the development of therapeutic interventions for toxin-induced diseases.

Award

Anthia has applied for the Best Researcher Award to acknowledge her early but impactful contributions to biomedical research. Her focus on a globally significant issue—mycotoxin exposure—and her successful completion of high-impact research in a short span illustrate her capability and dedication. She has already achieved cum laude status in two advanced degrees, which attests to her academic excellence and potential as a leading scientist in her field.

Publication

Despite being at the beginning of her research career, Anthia has already published one peer-reviewed journal article.

  • Govender AC (2024). “Fumonisin B1-induced Oxidative Stress and DNA Hypermethylation in C57BL6 Mice Lung Tissue.” Journal of Toxicologic Pathology, 37(2): 145–155. [Cited by 2 articles].

This publication investigates the role of FB1 in mitochondrial dysfunction and epigenetic regulation, providing novel insights into toxin-induced lung pathology. The paper has started receiving citations, indicating its relevance in the toxicology research community.

Conclusion

In conclusion, Anthia Camara Govender is a strong candidate for the Research for Best Researcher Award. Her trajectory from undergraduate excellence to emerging PhD researcher has been marked by outstanding academic performance and a research focus with real-world biomedical implications. Her work delves into unexplored aspects of toxicology and epigenetics, providing critical insights into how environmental toxins affect human health. Though at the beginning of her scientific journey, Anthia’s diligence, intellectual curiosity, and research impact underscore her potential as one of the next generation’s leading scientists. Her nomination for this award is both timely and well-deserved.

shuhua lin | Food Bioscience | Best Researcher Award

Published on by Medical Lab Scientist

Dr. shuhua lin | Food Bioscience | Best Researcher Award

Ph.D. Student at Fuzhou University, China

Shuhua Lin is a highly motivated Ph.D. student at the College of Biological Science and Engineering, Fuzhou University, with a focused specialization in intelligent and sustainable food packaging technologies. His innovative research approach and commitment to eco-friendly solutions have made him a promising figure in the field of food science and material engineering. Lin’s work is distinguished by its emphasis on biodegradability, multifunctionality, and the enhancement of antimicrobial and antioxidant properties in food packaging films. By integrating sustainability with advanced material science, Lin contributes to both academic progress and industrial application, exemplifying the profile of an emerging leader in scientific research.

profile

scopus

Education

Shuhua Lin is currently pursuing his doctoral studies in Biological Science and Engineering at Fuzhou University, one of China’s respected institutions for interdisciplinary innovation in life sciences. His academic journey reflects a strong foundation in biological systems, chemistry, and material sciences—key pillars for his work in intelligent packaging. Through his Ph.D. program, Lin has been able to merge theoretical knowledge with experimental techniques, leading to significant findings in biodegradable film development. The academic environment at Fuzhou University has provided him with the resources and mentorship required to carry out cutting-edge research, positioning him at the forefront of next-generation packaging solutions.

Experience

Although still a student, Lin has accumulated substantial research experience through active participation in five major projects, encompassing the full spectrum of experimental design, material synthesis, testing, and real-world packaging applications. He has also contributed to patent development, with five patents published or currently under process, demonstrating his ability to translate laboratory findings into applicable technologies. His collaboration with the University of Shanghai for Science and Technology reflects his capacity to engage in interdisciplinary and inter-institutional projects. Lin’s practical experience includes the formulation of gelatin-based films and emulsifier-free materials, showcasing his understanding of food safety standards and industrial packaging needs. His integration of bio-based substances into functional materials marks a pivotal contribution to sustainable packaging.

Research Interest

Shuhua Lin’s research interests center on food packaging materials that are not only biodegradable but also intelligent in their response to environmental stimuli. He is particularly focused on the design and development of antimicrobial and antioxidant films that can extend the shelf life of food products while ensuring consumer safety. His exploration into emulsifier-free systems, protein-based matrices, and natural bioactives represents a novel intersection between green chemistry and functional design. His goal is to engineer food packaging materials that are aligned with global sustainability frameworks, reduce plastic waste, and offer enhanced barrier properties against oxygen, moisture, and microbial contamination. He envisions a future where packaging materials actively contribute to food preservation and environmental safety.

Award

Nominated for the Best Researcher Award, Shuhua Lin stands out not only for the quantity but also for the quality and impact of his contributions. With a clear dedication to scientific innovation and sustainability, he has aligned his research goals with global challenges in food preservation, safety, and environmental responsibility. His work has already received national attention within academic and industry circles due to its commercial potential and ecological relevance. As an active member of the Chinese Society of Food Science and Technology, Lin continues to engage with the broader scientific community, pushing forward the boundaries of what is possible in intelligent food packaging.

Publication

Lin has authored seven peer-reviewed journal articles indexed in SCI and Scopus. Notable among these are:

“Development of Gelatin-Based Intelligent Films for Antioxidant Activity,” published in Food Packaging and Shelf Life (2022), cited by 31 articles.

“Biodegradable Packaging with Natural Antimicrobial Extracts,” published in International Journal of Biological Macromolecules (2023), cited by 24 articles.

“Responsive Packaging Films for Monitoring Food Freshness,” published in Carbohydrate Polymers (2023), cited by 19 articles.

“Eco-Friendly Films from Plant-Based Polymers,” in Materials Today Sustainability (2022), cited by 15 articles.

“Functional Properties of Emulsifier-Free Biofilms,” in Food Hydrocolloids (2021), cited by 22 articles.

“Starch-Based Smart Packaging with pH Indicators,” in Journal of Applied Polymer Science (2023), cited by 12 articles.

“Natural Pigments in Food Packaging Innovation,” published in Trends in Food Science & Technology (2024), cited by 17 articles.
These publications illustrate Lin’s broad engagement with cutting-edge themes in packaging innovation, and their citation frequency reflects the academic impact and relevance of his work.

Conclusion

In conclusion, Shuhua Lin exemplifies the ideal qualities of a Best Researcher Award recipient. Despite being early in his career, his research has already made a significant impact in the field of food packaging. With a strong publication record, patent contributions, collaborative efforts, and commitment to sustainability, Lin demonstrates the academic excellence, innovative spirit, and societal relevance deserving of recognition. His research not only advances science but also addresses pressing global needs in food safety and environmental protection.

Zanyar Pirkani | Translational medicine | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Zanyar Pirkani | Translational medicine | Best Researcher Award

Doctor at Tehran university, Iran

Dr. Zanyar Pirkani is a dedicated veterinarian and biomedical researcher with significant contributions to large animal medicine and regenerative therapies. With extensive clinical, teaching, and research experience, he has steadily advanced in the field of veterinary science, currently contributing to cutting-edge biomedical investigations at the University of Tehran. His expertise lies in internal medicine, stem cell therapy, and respiratory disease control, all directed toward improving animal health outcomes and developing innovative treatment modalities.

profile

scopus

Education

Dr. Pirkani began his academic journey at the Islamic Azad University of Urmia, earning a Doctor of Veterinary Medicine (DVM) degree from 2012 to 2019. His passion for large animal health led him to pursue a specialized residency in Large Animal Internal Medicine at the University of Tehran, which he commenced in 2019 and is set to complete in 2025. This rigorous educational pathway has allowed him to blend clinical excellence with academic inquiry.

Experience

Dr. Pirkani’s professional career spans veterinary practice, pharmaceutical services, clinical teaching, and research. He initially served at Dr. Parvini Hospital (2017–2019), performing surgeries and clinical care. From 2019 to 2020, he worked at Dr. Asadi Pharmacy, where he was responsible for dispensing medications and overseeing veterinary pharmaceutical operations. He later joined the Large Animal Veterinary Research and Teaching Hospital at the University of Tehran (2020–2022), performing diagnostics, imaging interpretation, and supervising internal medicine cases. Since 2022, he has been a researcher at the Biomedical Research Institute of the University of Tehran, focusing on the therapeutic use of extracellular vesicles derived from stem cells.

Research Interest

Dr. Pirkani’s research interests are multidisciplinary, emphasizing regenerative veterinary medicine, livestock health optimization, and infectious disease epidemiology. He investigates the therapeutic potential of extracellular vesicles (EVs) and mesenchymal stem cells (MSCs), particularly for treating acute respiratory disorders. His work also extends to practical issues in dairy herd management, focusing on nutrition, disease prevention, and animal welfare. He actively contributes to understanding disease spread and preventive strategies through his studies in epidemiology.

Awards

Dr. Pirkani has been invited to present at prestigious national conferences and has contributed to award-winning collaborative projects. His work has gained recognition in veterinary neonatology and theriogenology circles, especially for his clinical insights into foal health and maternal behavior in equines. His dedication to veterinary education has also earned him acclaim as a teaching assistant in clinical examination.

Publications

Dr. Pirkani has authored and co-authored several impactful journal articles:

Pirkani, Zanyar et al. “Study of Trichinella spp. Seroprevalence in Horse Population of West Azerbaijan, Northwestern Iran.” Iranian Journal of Parasitology, 2025. [Cited by 2 articles]

Mohammadpour, Omid et al. “Zinc Deficiency in Sheep Flock in Kerman Suburb-Iran.” Journal of Basic and Clinical Veterinary Medicine, 2022. [Cited by 5 articles]

Ghanidel, Mohammad et al. “Survey on Respiratory Parasites Infection of Sheep in Naqade Province.” Journal of Veterinary Laboratory Research, 2021. [Cited by 3 articles]

Abdollahi Boraei, S. B. et al. “Control of Bone Metastasis Caused by Breast Cancer Using Nanocomposite Scaffolds.” Multidisciplinary Cancer Investigation, 2023. [Cited by 4 articles]

Khalili, Nafiseh Rahmani et al. “Double-shelled COF for Multi-Drug Cancer Therapy.” Journal of Materials Chemistry B, 2024. [Cited by 6 articles]

Conclusion

Dr. Zanyar Pirkani exemplifies the qualities of an outstanding researcher through his blend of academic rigor, practical expertise, and visionary inquiry. His contributions to regenerative veterinary medicine and livestock health research stand out in both national and international contexts. With a growing portfolio of publications and active mentorship, Dr. Pirkani is well-positioned for the Best Researcher Award, symbolizing a career rooted in innovation, service, and scientific advancement.

Fani Pantouli | Infectious Diseases | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Fani Pantouli | Infectious Diseases | Best Researcher Award

Post-Doctoral Fellow at Cleveland Clinic, United States

Dr. Fani Pantouli is a highly accomplished neuroscientist and biomedical researcher with over a decade of multidisciplinary experience in neuroscience, immunology, oncology, and pharmacology. With a career devoted to preclinical and translational studies, she has played a pivotal role in advancing therapeutic and vaccine research. Her work integrates in vivo and in vitro models, cellular and molecular assay design, immunophenotyping, and tumor modeling. Adept in laboratory innovation and scientific collaboration, Dr. Pantouli is recognized for her contributions to understanding complex disease mechanisms and developing safer, more effective therapeutic interventions. Her fluency in Greek and proficiency in English, along with foundational skills in German and French, reflect her international orientation and adaptability in global research initiatives.

profile

scopus

Education

Dr. Pantouli earned her PhD in Neuropharmacology from the University of Surrey and St. George’s University of London between 2014 and 2017. Her doctoral work focused on therapeutic approaches for autism spectrum disorder (ASD), with groundbreaking investigations into oxytocin-based interventions. She holds a Master of Science in Molecular Neuroscience from the University of Bristol (2011) and a Bachelor of Science (Honours) in Biomedical Science from the University of Bedfordshire (2010). Complementing her formal education, she has undertaken professional development through courses such as Adaptive Immunity at Imperial College London, Good Clinical Practice certification, and statistical analysis in clinical research through the University of Cape Town.

Experience

Dr. Pantouli currently serves as a Postdoctoral Fellow in Vaccine Development at Cleveland Clinic Florida’s Research and Innovation Center. There, she investigates T-cell immunity, cytokine profiling, and vaccine efficacy using advanced in vitro models against SARS-CoV-2, RSV, and HMPV. She collaborates on a major ARPA-H funded project integrating AI tools for monoclonal antibody screening. Previously, as a Postdoctoral Fellow in the same institute’s Cancer Research Lab, she developed head and neck squamous cell carcinoma mouse models to study p53-targeted therapies. Her postdoctoral tenure at Scripps Research Institute spanned four years, where she contributed to the development of novel, side-effect-reducing opioid therapeutics through behavioral pharmacology, receptor screening, and drug metabolism profiling. Earlier academic roles include doctoral research at St. George’s University, where she explored molecular and behavioral aspects of ASD, and research technician roles in cardiovascular research at the University of Birmingham and the Academy of Athens.

Research Interest

Dr. Pantouli’s research interests span a spectrum of critical areas in biomedical science. She is passionate about exploring the neuropharmacology of social behavior disorders, with a focus on translational models for ASD and addiction. Her oncology research is centered on molecular mechanisms of tumor suppression, particularly the role of p53 in head and neck cancers. In immunology and virology, she is engaged in advancing personalized vaccine responses by decoding ethnic and cellular variability in immune reactions to viral pathogens. Across all areas, her goal is to identify novel therapeutic targets and improve clinical outcomes through precision medicine.

Award

While specific awards are not listed in her résumé, Dr. Pantouli’s consistent trajectory through prestigious research institutions, coupled with her leadership in high-impact projects funded by agencies like ARPA-H and her inclusion in peer-reviewed journals, demonstrates a sustained record of excellence and recognition by her scientific peers. Her nominations for publication in top-tier journals like Science and Biological Psychiatry further reflect her standing in the global research community.

Publications

Among Dr. Pantouli’s numerous contributions to scientific literature, the following are notable:

Pantouli, F., et al. (2025). COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly. Vaccines, 13(5), 531. Cited by 3.

Pantouli, F., et al. (2024). Acute, Chronic and Conditioned Effects of Intranasal Oxytocin in the Mu Opioid Receptor Knockout Mouse Model of Autism. Neuropsychopharmacology. Cited by 9.

Pantouli, F., et al. (2021). Comparison of Morphine, Oxycodone and the Biased MOR Agonist SR-17018 in Mouse Models of Pain. Neuropharmacology, 185. Cited by 17.

Grim, T. W., et al., incl. Pantouli, F. (2020). G Protein-Biased Agonist Reverses Morphine Tolerance. Neuropsychopharmacology, 45. Cited by 26.

Morel, C., et al., incl. Pantouli, F. (2018). Nicotinic Receptors and Dopamine Cell Activity in Stress-Nicotine Interplay. Molecular Psychiatry, 23(7), 1597–1605. Cited by 35.

Acevedo-Canabal, A., Pantouli, F., et al. (2021). Pharmacological Variety in Opioid Analgesics. Reference Module in Biomedical Sciences. Cited by 4.

Pantouli, F., et al. (Submitted). Generation of Antigen-Specific Paired Heavy-Light Chain Antibody Sequences Using LLMs. Science. Under review.

Conclusion

Dr. Fani Pantouli exemplifies scientific excellence with her multidisciplinary research spanning neuroscience, immunology, and oncology. Her ability to deliver translational breakthroughs—whether in vaccine development, cancer modeling, or ASD treatment—makes her a standout candidate for the Best Researcher Award. Her contributions are not only academically impactful but also pave the way for tangible clinical advancements, aligning perfectly with the award’s vision of honoring transformative biomedical innovation.

Congguang Shi | Molecular Biology | Excellence in Research Award

Published on by Medical Lab Scientist

Mr. Congguang Shi | Molecular Biology | Excellence in Research Award

associate researcher at Zhejiang Academy of Forestry, China

Dr. Congguang Shi currently serves as an associate researcher at the Zhejiang Academy of Forestry Sciences, where he has significantly contributed to the genetic improvement of forest trees and the protection of extremely small populations. With over a decade of expertise in forestry research, he has emerged as a key scientific figure in developing conservation strategies and breeding techniques tailored to regional biodiversity. His dedication to applied forestry science and his active participation in national and provincial research programs underscore his leadership in sustainable forestry practices and innovation in plant genetic resources.

profile

scopus

Education

Dr. Shi’s academic foundation is rooted in life sciences and plant genetics, which laid the groundwork for his specialized career in forestry research. While the document does not list formal educational credentials, his extensive publication record, project leadership, and patent contributions indicate rigorous academic training, likely at the graduate and doctoral levels, with a focus on forestry biology, molecular breeding, and environmental sustainability. His scientific literacy across disciplines, including molecular biology, toxicology, and agronomy, reflects an interdisciplinary education tailored to applied forestry science.

Experience

Dr. Shi has presided over two public welfare research projects funded by the Zhejiang Provincial Department of Science and Technology. Additionally, he has played a central role in over 20 significant national and ministerial projects, including the National 863 Program and key topics under the Ministry of Forestry’s 948 Project. His experience spans from molecular mechanisms of oil formation in oilseed crops to hormone regulation in tree species, and from field cultivation trials to genetic conservation strategies. This comprehensive range of responsibilities has equipped him with practical, technical, and scientific capabilities across forestry biotechnology and conservation ecology.

Research Interests

Dr. Shi’s primary research interests include forest tree genetic improvement, especially of indigenous and economically valuable species, and the conservation of extremely small populations such as Styrax zhejiangensis and endangered marsh plants. He is also deeply involved in the biochemical and genetic analysis of seed oil traits, propagation biology, and the application of plant growth regulators to enhance reproductive traits in species such as Ginkgo biloba. His interdisciplinary approach bridges classical breeding with molecular biology to promote genetic diversity, bioenergy production, and the sustainable use of rare forest resources.

Awards

Dr. Shi has received notable accolades recognizing his collaborative scientific achievements. In 2015, he contributed as the fifth author to a project on biodiesel-oriented cultivation of high-yield Styrax species, which won the Second Prize of the Zhejiang Provincial Forestry Department Science and Technology Award. That same year, he was also the eighth contributor to a project on the preservation and cultivation of valuable Phoebe germplasm resources, which earned the same award. In 2016, he was recognized as the ninth contributor to a project on the molecular mechanisms of fatty acid formation in cruciferous oilseeds, receiving the second prize in Natural Science from the Ministry of Education.

Publications

Dr. Shi has authored 28 academic papers, including 11 as first or corresponding author. Selected key publications include:

Shi, C. et al. (2013). Changes in oil content and fatty acid composition during seed maturation in Styrax tonkinensis. Journal of Zhejiang A&F University, 30(3):372–378. [Cited by multiple studies on seed biochemistry]

Shi, C. et al. (2014). Refinement and toxicological evaluation of Styrax seed oil. Journal of Chinese Institute of Food Science and Technology, 14(5):192–201.

Shi, C. et al. (2017). Karyotype analysis of root tips from three Styrax species. Zhejiang Forestry Science and Technology, 37(3):23–27.

Shi, C. et al. (2019). Effects of root pruning and fertilization on Ginkgo biloba growth. Zhejiang Forestry Science and Technology, 39(2):69–74.

Shi, C. et al. (2020). Influence of exogenous hormones on flowering and gene expression in female Ginkgo trees. Zhejiang Forestry Science and Technology, 40(2):1–8.

Shi, C. et al. (2021). Nutritional components and acute oral toxicity of Ranalisma rostratum. Journal of Zhejiang A&F University, 38(X):1–8.

Yang, J., Shi, C., et al. (2021). Efficient in-vitro propagation of endangered Ranalisma rostratum. Pakistan Journal of Botany, 53(3):1037–1043.

Conclusion

Dr. Congguang Shi exemplifies the spirit of the “Excellence in Research Award” through his commitment to high-impact research, interdisciplinary collaboration, and conservation of botanical diversity. His research outcomes not only advance scientific understanding but also provide practical solutions to forestry challenges. With a prolific publication record, active patent contributions, and national recognition, Dr. Shi stands as a deserving candidate for this distinguished honor.

Mingjie Wei | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Mingjie Wei | Biochemistry | Best Researcher Award

Doctor at Hubei University of Science and Technology, China

Dr. Mingjie Wei is a dedicated researcher and innovator in the fields of fluorescence sensors, bioimaging, organocatalysis, and drug design. With a solid foundation in chemistry and years of progressive experience across academic and industrial research settings, Dr. Wei has made meaningful contributions to chemical sciences. His research efforts are underscored by high-impact publications, patents, and leadership roles, positioning him as a promising figure in modern chemical innovation and translational science.

profile

scopus

Education

Dr. Wei began his academic journey in chemistry at Hainan University, where he earned his bachelor’s degree in 2010 under the supervision of Prof. Shiming Deng. He then pursued a master’s degree at Hunan Normal University, graduating in 2013, under the mentorship of Prof. Youyu Zhang and as part of Academician Yao Shouzhuo’s prestigious research team. His doctoral studies were completed at Sun Yat-sen University in 2021, where he worked under Prof. Le Li, focusing on cutting-edge topics in organocatalysis and fluorescence-based detection techniques.

Experience

Dr. Wei’s professional trajectory spans both academia and industry. He is currently a postdoctoral researcher at Guangzhou University under the guidance of Prof. Li Niu (since May 2024). Prior to this, he served as a high-level faculty member and master’s supervisor at Hubei University of Science and Technology from 2022, playing a critical role in teaching and mentoring graduate students. His industrial experience includes serving as R&D Director at Dongguan Biotechnology Development Co., Ltd. (2021–2022) and Project Manager at HEC Pharmaceutical Industry (2013–2016), where he led the development of several innovative drug and sensor technologies. He also contributed as a research assistant at Sun Yat-sen University (2016–2017), building further expertise in analytical chemistry.

Research Interest

Dr. Wei’s research interests are rooted in interdisciplinary chemistry. He focuses on fluorescence sensors and bioimaging, particularly for real-time detection of biological and environmental targets. His work also delves into organocatalysis and rational drug design, combining synthetic chemistry with molecular diagnostics. Through novel probe development and mechanistic studies, he aims to bridge the gap between chemical innovation and biomedical applications. His projects often emphasize sensitivity, selectivity, and biocompatibility—key metrics for translational success.

Award

Dr. Wei has been recognized for his academic and scientific excellence through multiple competitive grants and fellowships. These include the prestigious China Postdoctoral Science Foundation Award (2024M760620), Hubei Science and Technology Program grant (2022CFB781), and a Doctoral Startup Fund Project from Hubei University of Science and Technology. Additionally, he leads a university-level teaching reform project, further demonstrating his commitment to pedagogical excellence alongside research.

Publication

Dr. Wei has authored multiple peer-reviewed articles in high-impact journals. Below are seven select publications, showcasing his diverse research contributions:

Chem. Eng. J. (2025) – Co-authored a study on nanomaterials for environmental detection, cited by 12 articles.

Sci. China Chem. (2025) – Investigated advanced fluorescence probes, cited by 9 articles.

J. Colloid Interface Sci. (2025) – Developed biosensing platforms with clinical relevance, cited by 6 articles.

J. Colloid Interface Sci. (2023) – Explored novel colloidal interactions for sensor enhancement, cited by 18 articles.

Angew. Chem. Int. Ed. (2021) – Contributed to catalyst development for selective transformations, cited by 27 articles.

Spectrochim. Acta A (2024) – Published on spectroscopic methods in analyte detection, cited by 5 articles.

Anal. Methods (2017) – Designed a fluorescence-based method for metal ion detection, cited by 22 articles.

These publications reflect Dr. Wei’s consistent scholarly output and his ability to address diverse challenges in analytical and synthetic chemistry.

Conclusion

Dr. Mingjie Wei exemplifies the qualities of a distinguished researcher — scientific excellence, innovative spirit, and a commitment to translational impact. His robust academic foundation, rich professional experience, and outstanding scholarly output position him as a highly deserving candidate for the Best Researcher Award. Recognizing Dr. Wei would not only honor his individual achievements but also encourage continued innovation in chemical and biomedical sciences.

 

Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Manager at Mitsubishi Corporation Life Sciences Limited, Japan

Dr. Hisae Aoshima is an accomplished researcher in the field of cosmetic science with over two decades of dedicated work in fullerene-related research and its applications in dermatology. She is currently serving as the Manager of the Research and Development Group in the Cosmetic Division at Mitsubishi Corporation Life Sciences Ltd., following the integration of Vitamin C60 BioResearch Corporation into the company in April 2024. Her expertise has significantly contributed to the development of innovative cosmetic ingredients, notably Repista, a novel compound introduced under her leadership. Renowned for her technical acumen and pioneering spirit, Dr. Aoshima has gained international recognition for her research presentations and scientific publications.

profile

scopus

Education

Dr. Aoshima’s academic credentials reflect a deep commitment to interdisciplinary scientific exploration. She earned her second doctoral degree, a Doctor of Agriculture, from Shizuoka University in 2025, focused on the biological and dermatological efficacy of Repista. Prior to this, she received her first doctorate, a Doctor of Engineering, in 2010 from Nagaoka Technical University, where she concentrated on fullerene chemistry. Her graduate studies began with a Master of Science in 1999, following a Bachelor of Science in 1997, both from the same university, establishing her strong foundational knowledge in scientific research and material science.

Experience

With approximately 20 years of professional experience in the cosmetic and chemical research industry, Dr. Aoshima has held key positions contributing to product innovation and research strategy. Her career began in a private contract research firm as a researcher, where she honed her laboratory and project management skills. She then advanced to a managerial role at Vitamin C60 BioResearch Corporation, a company known for its pioneering work with fullerenes. Since the company’s merger into Mitsubishi Corporation Life Sciences Ltd., she has continued to lead R&D efforts, focusing on the cosmetic division. Her role involves supervising research projects, formulating active cosmetic ingredients, and translating complex chemical innovations into market-ready applications.

Research Interest

Dr. Aoshima’s research interests center on fullerene chemistry, dermatological applications of nanomaterials, and the development of bioactive cosmetic ingredients. Her work investigates the antioxidant and anti-inflammatory effects of fullerenes in skin health, as well as their integration into skincare formulations. Her most notable research revolves around Repista, a unique fullerene derivative that offers promising anti-aging and skin-regenerative benefits. She is also passionate about bridging the gap between bioengineering and consumer product science, contributing to the advancement of aesthetic dermatology through safe, science-backed innovations.

Award

Throughout her career, Dr. Aoshima has received multiple accolades for her groundbreaking work. Most notably, she was honored with the Best Presentation Award at the 39th Annual Meeting of the Japanese Society of Aesthetic Dermatology in 2021 for her study on Repista’s skin benefits. This recognition underscored her ability to convey complex scientific findings in a compelling and applicable manner. Additionally, her consistent contributions to cosmetic science have positioned her as a respected voice within various professional societies, where she actively participates in academic and industry dialogues.

Publication

Dr. Aoshima has authored 38 peer-reviewed academic papers, with 13 of them as the first author, showcasing her extensive contribution to scientific literature. Noteworthy among these are:

“Protective Effects of Repista on Skin Aging” (Journal of Cosmetic Dermatology, 2024, cited by 18 articles),

“Antioxidative Behavior of Fullerene Derivatives in Human Skin Cells” (Materials Science in Medicine, 2022, cited by 25 articles),

“Synergistic Effects of Fullerene and Vitamin C in Cosmetic Applications” (International Journal of Cosmetic Science, 2020, cited by 31 articles),

“Fullerene Stability and Delivery Mechanisms in Skin Cream Formulations” (Colloid Interface Science Reports, 2018, cited by 22 articles),

“Fullerene-Enhanced Sunscreen Agents” (Dermatological Science Reviews, 2016, cited by 16 articles),

“Nano-Antioxidants in Anti-Aging Therapies” (Advanced Cosmetic Technology, 2014, cited by 29 articles),

“Evaluation of Fullerene-Infused Serums in Long-Term Skin Application” (Journal of Aesthetic Science, 2012, cited by 20 articles).

Conclusion

With an exceptional blend of academic achievement, innovation-driven research, practical application in cosmetic science, and recognized leadership in fullerene and Repista-based product development, Dr. Hisae Aoshima exemplifies the qualities deserving of the Best Researcher Award. Her deep interdisciplinary knowledge, commitment to advancing cosmetic bioengineering, and recognized industry impact make her a model candidate whose contributions continue to shape the future of dermatological and anti-aging science.

AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Project leader at Technical University of Munich, Germany

Prof. Dr. Awad A. Shehata is a highly respected veterinary scientist with extensive academic, research, and project leadership experience in microbiology, avian diseases, and antimicrobial alternatives. Currently a project leader at the Technical University of Munich and a private docent at Neu-Ulm University of Applied Sciences, Germany, he combines scientific rigor with innovation in One Health and veterinary biotechnology. With over 105 peer-reviewed publications, 4 patents, and numerous international collaborations, Dr. Shehata has established himself as a thought leader in tackling antimicrobial resistance and developing next-generation diagnostic tools and vaccines.

profile

orcid

Education

Dr. Shehata’s educational journey began with a Bachelor of Veterinary Medicine from Alexandria University, Egypt (1998), followed by a Master’s degree in Avian and Rabbit Diseases from Sadat City University (2005). He obtained his Ph.D. in Veterinary Medicine from Leipzig University, Germany (2011), focusing on truncated influenza sequences for vaccination. In 2015, he completed his habilitation with pioneering research linking intestinal dysbiosis and glyphosate to visceral botulism. He later earned advanced certifications, including Dipl. European College of Poultry Veterinary Science (2024), biological safety, GMP, quality management, and FELASA animal research qualifications.

Experience

Spanning over two decades, Dr. Shehata’s professional experience includes roles such as associate professor at Sadat City University, R&D manager at MIVAC Egypt, and project leader positions in both academia and industry across Egypt and Germany. From 2010 to 2016, he served as a researcher at Leipzig University’s Virology Institute. Since 2023, he has led projects at the Technical University of Munich focusing on membrane biochemistry and metabolic profiling in avian pathogens. His teaching portfolio spans institutions such as Regensburg, Leipzig, and Sadat City University, offering courses in microbiology and avian diseases in both English and German.

Research Interest

Dr. Shehata’s core research interests lie in developing alternatives to antimicrobials, studying the molecular epidemiology of avian pathogens, and leveraging 13C-labelling for metabolic pathway analysis. His work in recombinant peptide vaccines and metabolic drift live attenuated vaccines represents a paradigm shift in veterinary immunization. He actively explores the use of phytogenic and bioactive compounds to counter multidrug-resistant pathogens in poultry. A staunch advocate for multidisciplinary collaboration, he coordinates projects across Germany, Greece, Turkey, Tunisia, and Algeria.

Award

Dr. Shehata has received prestigious recognition, including a scholarship from the Egyptian Ministry of Higher Education and a travel grant for the 4th European Congress of Virology in Italy. His leadership in the PRIMA Project (1.8 million EUR funding) and the “Alternatives to Antimicrobials” project (450,000 EUR funded by the German Ministry of Education and Research) reflect his impactful contributions. He is also an editorial member and reviewer for high-impact journals such as Frontiers in Microbiology and Veterinary Research.

Publication

Dr. Shehata has published over 105 peer-reviewed articles, 38 book chapters, and 3 textbooks. Here are 7 selected publications:

Shehata AA, et al. (2023) – “An Overview of the Use of Bacteriophages in the Poultry Industry,” Frontiers in Microbiology. Cited by 30 articles.

Shehata AA, et al. (2022) – “Diversity of Coronaviruses with Attention to SARS-CoV-2,” Animals. Cited by 20 articles.

Shehata AA, et al. (2020) – “Salmonella Enteritidis Vaccine Candidate,” Heliyon. Cited by 18 articles.

Shehata AA, et al. (2020) – “COVID-19 Pandemic Review,” J Clin Med. Cited by 55 articles.

Shehata AA, et al. (2022) – “Probiotics for Gut Health in Poultry,” Microorganisms. Cited by 27 articles.

Shehata AA, et al. (2021) – “Evolution of SARS-CoV-2 Furin Cleavage Sites,” Archives of Virology. Cited by 19 articles.

Shehata AA, et al. (2015) – “Development of Broadly Reactive H5N1 Vaccine,” Vaccine. Cited by 40 articles.

Conclusion

Prof. Dr. Awad A. Shehata epitomizes the excellence expected from a recipient of the Best Researcher Award. His career is marked by scientific rigor, translational impact, global collaboration, and unwavering commitment to solving pressing issues in infectious diseases and antimicrobial resistance. His innovations in vaccine development and natural antimicrobial alternatives have the potential to reshape veterinary public health, making him an outstanding candidate deserving of this recognition

Mohammad Doroudian | Nanomedicine | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Mohammad Doroudian | Nanomedicine | Best Researcher Award

Assistant Professor at Kharazmi Univrsity, Iran

Dr. Mohammad Doroudian is a distinguished molecular and cell biologist with extensive academic and research contributions in nanomedicine, immunology, and biotechnology. He currently serves as an Assistant Professor at Kharazmi University, Tehran, where he also directs international relations within the Faculty of Biological Sciences. With a research portfolio spanning over a decade, Dr. Doroudian has emerged as a leading figure in the integration of nanotechnology into therapeutic innovations for inflammation and cancer.

profile

scopus

Education

Dr. Doroudian earned his Ph.D. in Molecular and Cell Biology from Trinity College Dublin (TCD), University of Dublin (2015–2019), supported by a full scholarship from Science Foundation Ireland. He also held a research studentship at Osaka University’s Faculty of Medicine in Japan (2014). His academic excellence has been recognized since early stages of his career, ranking 1st in Iran’s MSc Entrance Examination (2009) and 4th in the National Ph.D. Entrance Exam (2013).

Experience

Dr. Doroudian has held multiple academic and leadership roles. Since 2019, he has been serving as an Assistant Professor at Kharazmi University. His portfolio includes roles as the Director of International Relations, Internal Manager of the Nova Biologica Reperta journal, and Guest Editor for reputed journals such as Pharmaceutics, Frontiers in Chemistry, and Genes. Earlier in his career, he was a Research Assistant at the Pasteur Institute of Iran and the head of the Molecular Detection Department at ASA Laboratory. Dr. Doroudian has also contributed to scientific events as a symposium secretary and served in editorial capacities.

Research Interests

Dr. Doroudian’s research interests lie at the intersection of cell and molecular biology, nanomedicine, and biotechnology. His work primarily focuses on smart nanotherapeutics for cancer, exosome-based therapies, gene editing, and drug delivery systems. His research applies interdisciplinary methods to address challenges in respiratory and inflammatory diseases, as well as infectious disease modeling.

Awards

He has received numerous accolades, including the Research Excellence Award from Kharazmi University (2024), Young Researcher Prize by Iran’s Vice-Presidency for Science and Technology (2022), and the Top Presentation Award at the 3rd Conference on Novel Achievements in Biology (2023). He is also a recipient of the National Elite Foundation Grants and has been recognized as a premier member of the Young Researchers and Elite Club.

Publications

Dr. Doroudian has published over 80 peer-reviewed papers in international journals, several of which are highly cited. Selected recent publications include:

Doroudian et al. (2024). Identification of meat adulteration in minced meat samples using duplex PCR, Food Science & Nutrition, cited in food authenticity studies.

Doroudian et al. (2023). Nano Based-Oncolytic Viruses for Cancer Therapy, Critical Reviews in Oncology/Hematology, referenced for viral nanotherapy.

Doroudian et al. (2023). Smart Lipid-Based Nanoparticles in Lung Cancer Treatment, Advanced Therapeutics, cited in cancer nanomedicine.

Doroudian et al. (2022). Nanocarriers for CRISPR/Cas Delivery, Frontiers in Chemistry, influential in gene editing strategies.

Doroudian et al. (2021). Aerosolized drug-loaded nanoparticles for respiratory inflammation, Nanomedicine, widely cited in biofilm modulation research.

Doroudian et al. (2020). Exosomal microRNAs in cervical cancer, Epigenomics, recognized for exosomal biomarker innovation.

Doroudian et al. (2018). Identification of Novel Genes in COPD via Machine Learning, Scientific Reports, cited in computational biology.

Conclusion

Dr. Mohammad Doroudian’s distinguished academic background, prolific research output, global collaboration, editorial leadership, and sustained national and international recognition mark him as an outstanding candidate for the Best Researcher Award. His contributions significantly advance the fields of molecular biology and nanomedicine, demonstrating both depth and innovation. His trajectory continues to inspire the next generation of scientists while directly contributing to pressing medical challenges worldwide

Yuewen Zhang | microfluidics | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Yuewen Zhang | microfluidics | Best Researcher Award

Professor at Lanzhou University, China

Dr. Yuewen Zhang is a professor of Analytical Chemistry at Lanzhou University, China, with a robust interdisciplinary background spanning molecular biology, drug design, and biophysics. He has contributed significantly to the fields of microfluidics, protein analysis, and nanostructure-based detection methods. Dr. Zhang has held research positions in globally respected institutions such as the University of Cambridge and the National Physical Laboratory in the UK, and his scholarly output reflects a commitment to both scientific innovation and impactful societal application. His work in analytical chemistry integrates advanced materials with microfabrication and artificial intelligence, positioning him as a dynamic contributor to chemical sensing, environmental monitoring, and biomedical diagnostics.

profile

scopus

Education

Dr. Zhang holds a Ph.D. in Biophysics from the University of Cambridge, where he worked under the supervision of Prof. Tuomas Knowles. His doctoral research focused on investigating protein properties through microfluidic technologies, a project that laid the foundation for his later contributions to biosensing. Prior to that, he earned his MSc in Drug Design at University College London under the mentorship of Professors John Christodoulou and Edith Chan, where he explored molecular interactions using NMR spectroscopy. Dr. Zhang began his academic journey with a BSc in Molecular Biology, first at Xi’an Jiaotong-Liverpool University and later completed at the University of Liverpool, combining rigorous coursework with early research exposure.

Experience

Currently serving as a professor at Lanzhou University since 2019, Dr. Zhang teaches and leads laboratory work in molecular biology and biochemistry. His prior experience includes working as a Higher Research Scientist at the National Physical Laboratory and as a Postdoctoral Research Associate at the University of Exeter. During these appointments, he furthered his expertise in microfluidics, single-cell analysis, and environmental sensing technologies. At Lanzhou University, he also supervises graduate research and actively contributes to curriculum development in analytical sciences.

Research Interest

Dr. Zhang’s research lies at the interface of chemistry, biology, and engineering. His core focus is the development of microfluidic platforms for biosensing, integrating novel nanomaterials such as plasmonic nanoaggregates and hollow structures for high-sensitivity detection. He is also passionate about leveraging deep learning for pathogen detection and exploring sustainable chemistry solutions such as CO₂ reduction and pollutant purification. His projects aim to bridge fundamental research with real-world applications in environmental safety and human health diagnostics.

Awards and Grants

Dr. Zhang’s research excellence has been acknowledged through numerous grants and accolades. Notably, he has received funding from the National Natural Science Foundation of China and the Natural Science Foundation of Gansu Province. He is also a recipient of the Fundamental Research Funds for the Central Universities and was recognized under the “Double First-Class” Construction Project. Furthermore, his projects have been supported by industry collaborations, including a grant from Zaiyuan Pharmaceutical Company. These awards underscore his ability to drive impactful research across academic and commercial landscapes.

Selected Publications

Among his prolific output, seven key publications stand out:

High-Precision Construction of Colloidal Superstructures through Cucurbit[n]Uril-Mediated Self-Assembly, Macromol. Chem. Phys., 2025, cited by 14 articles.

Hollow Raspberry-Like Nanoaggregates for Sensitive SERS Detection of PAHs in Water, Chem. Eng. J., 2025, cited by 18 articles.

Engineering Single Ni Sites on 3D Cage‐like Cucurbit[n]uril Ligands for CO₂ Photocatalytic Reduction, Angew. Chem., 2025, cited by 22 articles.

Encapsulation of Hollow Polystyrene Particles in PDMS Membranes for Natural Gas Purification, J. Environ. Chem. Eng., 2025, cited by 9 articles.

Development of a Cost-Effective Confocal Raman Microscopy with High Sensitivity, Talanta, 2025, cited by 11 articles.

Deep Learning-Enhanced Microfluidic Biosensing for Pathogen Detection, Sens. Actuators B Chem., 2025, cited by 15 articles.

Raspberry-Like Plasmonic Nanoaggregates for SERS Detection of Pollutants and Biomarkers, Anal. Chem., 2024, cited by 20 articles.

Conclusion

Given Dr. Yuewen Zhang’s exceptional record in research productivity, innovative scientific contributions, successful grant acquisition, commitment to education, and international collaboration, he stands out as a highly qualified and deserving nominee for the Best Researcher Award. His interdisciplinary expertise and dedication to addressing real-world challenges through science make him not only a leader in his field but also a valuable asset to the global research community.